dexamedium 0,85 mg/ml injekčná suspenzia
intervet international b.v., holandsko - inj.
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastické činidlá - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
médiá ivd kultivačné lms
labmediaservis s.r.o. národní 84 551 01 jaroměř Česká republika -
médiá kultivačné biolife italiana
biolife italiana srl. viale monza 272 20128 milano taliansko -
médiá kultivačné dehydratované himedia m
himedia laboratories pvt. ltd. mumbai, india india -
médiá kultivačné himedia sl
himedia laboratories pvt. ltd. mumbai, india india -
média pre hemokultivácie himedia lq
himedia laboratories pvt. ltd. mumbai, india india -
médium izolačné mycoplasma preparation ivd - ostatné
biomérieux s.a. 376 chemin de l´orme 69280 marcy l´etoile francúzsko -
médium kultivačné cm, pm. lr, db oxion
oxoid ltd wade road basingstoke, hampshire spojené kráľovstvo veľkej británie a severného Írska -